The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: A novel mechanism of regulation of IL-1 responsiveness

被引:0
|
作者
Lang, D
Knop, J
Wesche, H
Raffetseder, U
Kurrle, R
Boraschi, D
Martin, MU
机构
[1] Med Hsch Hannover, Inst Mol Pharmakol, D-30623 Hannover, Germany
[2] Hoechst Marion Roussel, DG Rheumatol, Wiesbaden, Germany
[3] Dompe Res Ctr, I-67100 Laquila, Italy
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 161卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 binds to two types of receptors on the cell membrane, of which only type I (IL-1RI) transduces signals in concert with the coreceptor IL-1 receptor accessory protein (IL-1RAcP) while type II (IL-1RII) allegedly functions solely as ligand sink and decoy receptor without participating in IL-1 signaling. To investigate the regulatory Role of IL-1RII on IL-1 responsiveness, a chimeric receptor encompassing the extracellular and transmembrane portions of IL-1RII and the cytoplasmic signal-transducing domain of IL-1RI was transfected into two murine EL-4-derived sublines that do or do not express IL-1RAcP, respectively. The chimeric receptor was able to transduce the IL-1 signal and induce IL-2 production only in the cell line which expressed IL-1RAcP, suggesting effective interaction between the extracellular domains of IL-1RII and IL-1RAcP in the presence of IL-1, The physical association of ligated IL-1RII with IL-1RAcP was proven by crosslinking experiments with radio-iodinated IL-l and subsequent immunoprecipitations in normal human B cells and in EL-4 D6/76 cells transiently cotransfected with IL-1RII and IL-1RAcP, respectively. Based on these findings, it is proposed that upon IL-1 binding IL-1RII can recruit IL-1RAcP into a nonfunctional trimeric complex and thus modulate IL-1 signaling by subtracting the coreceptor molecule from the signaling IL-1RI, In this novel mechanism of coreceptor competition, the ratio between IL-1RII and IL-1RI becomes the central factor in determining the IL-1 responsiveness of a cell and the availability of IL-1RAcP becomes limiting for effective IL-1 signaling.
引用
收藏
页码:6871 / 6877
页数:7
相关论文
共 50 条
  • [1] IL-1 receptor accessory protein is an essential component of the IL-1 receptor
    Cullinan, EB
    Kwee, L
    Nunes, P
    Shuster, DJ
    Ju, G
    McIntyre, KW
    Chizzonite, RA
    Labow, MA
    JOURNAL OF IMMUNOLOGY, 1998, 161 (10): : 5614 - 5620
  • [2] Effects of IL-1 receptor accessory protein on IL-1 binding
    Wesche, H
    Resch, K
    Martin, MU
    FEBS LETTERS, 1998, 429 (03) : 303 - 306
  • [3] Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding:: Regulation of IL-1 responses is via type I receptor, not the accessory protein
    Yoon, DY
    Dinarello, CA
    JOURNAL OF IMMUNOLOGY, 1998, 160 (07): : 3170 - 3179
  • [4] Regulation of IL-1 by IL-1 decoy receptor
    Cheryl Smythe
    Arthritis Research & Therapy, 3 (1)
  • [5] Distinct mechanisms of IL-1 inhibition revealed by in vitro modeling of IL-1 receptor accessory protein interaction with IL-1/IL-1 receptor complex.
    Witt, A
    Vezina, C
    Qian, X
    Varnum, B
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S81 - S81
  • [6] Analysis of interleukin (IL)-Iβ IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders
    Libra, M
    Mangano, K
    Anzaldi, M
    Quattrocchi, C
    Donia, M
    Di Marco, R
    Signorelli, S
    Scalia, G
    Zignego, AL
    De Re, V
    Mazzarino, MC
    Nicoletti, F
    ONCOLOGY REPORTS, 2006, 15 (05) : 1305 - 1308
  • [7] The IL-1 system in HIV infection: Peripheral concentrations of IL-1 beta, IL-1 receptor antagonist and soluble IL-1 receptor type II
    Kreuzer, KA
    Dayer, JM
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 54 - 58
  • [8] IL-1β, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders
    Tominaga, K
    Habu, M
    Sukedai, M
    Hirota, Y
    Takahashi, T
    Fukuda, J
    ARCHIVES OF ORAL BIOLOGY, 2004, 49 (06) : 493 - 499
  • [9] IL-1 Receptor Accessory Protein-Ig/IL-1 Receptor Type II-Ig Heterodimer Inhibits IL-1 Response More Strongly than Other IL-1 Blocking Biopharmaceutical Agents
    Hanawa, Haruo
    Ota, Yoshimi
    Ding, Limin
    Chang, He
    Yoshida, Kaori
    Otaki, Keita
    Hao, Kazuhisa
    Kasahara, Sou
    Kodama, Makoto
    Nakazawa, Mikio
    Aizawa, Yoshifusa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (03) : 455 - 464
  • [10] IL-1 Receptor Accessory Protein-Ig/IL-1 Receptor Type II-Ig Heterodimer Inhibits IL-1 Response More Strongly than Other IL-1 Blocking Biopharmaceutical Agents
    Haruo Hanawa
    Yoshimi Ota
    Limin Ding
    He Chang
    Kaori Yoshida
    Keita Otaki
    Kazuhisa Hao
    Sou Kasahara
    Makoto Kodama
    Mikio Nakazawa
    Yoshifusa Aizawa
    Journal of Clinical Immunology, 2011, 31 : 455 - 464